Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by floatinketucky


V.TLT

$TLTFF WHATS THE TREND?

IS THE TREND YOUR FRIEND? TLTFF The science is strong. TLTFF Long.

February 11, 2022

V.TLT

$TLTFF Fancy like Applebees on date night$$!!.

NMIBC NONRESPONSE FIRST IN CLASS Theralase® Demonstrates Proof-of...

February 11, 2022

V.TLT

$TLTFF PI SAY go FDA darlin! FULL STRENGH FULL THROTTLE

Watch out boys.. shes about to cut a rug!!!{^youtubevideo|(width)425|(height...

February 10, 2022

V.TLT

$TLTFF Three month chart show current market digestion.

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

February 10, 2022

V.TLT

$TLTFF ITS ALL TRUE ITS ALL TRUE...

What do you tink about BTD AA and PRI-GROOVITYITY Review?? The PI said it...

February 10, 2022

V.TLT

$TLTFF THE STONGEST CHOICE FOR NMIBC NONRESPONSE.

67 %CR AT 18 months from one treatment. Patients then were released from the...

February 10, 2022

V.TLT

$TLTFF BTD AA Priority Review

FDA NMIBC NONRESPONSE. Darling xray activation for the next gear to rollers!...

February 9, 2022

V.TLT

$TLTFF Fancy like Applebees on date night.

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

February 9, 2022

V.TLT

How much money has the philantopist given away?

An just how widE did they throw open the door for the little FDA NMIBC...

February 9, 2022

V.TLT

Market confidence is strong in this one.

$TLTFF Three-month chart shows market confidence in Theralase.{^youtubevideo|...

February 9, 2022

V.TLT

$TLTFF 67% CR ON ONE TREATMENT FULL DOSE

@ 18 MONTHS. PHASE ONE STUDY.  The science is solid. $TLTFF Bullish...

February 9, 2022

V.TLT

$TLTFF Destruction Of Cervical Cancer

Theralase Anti-Cancer Drugs Effective In The Destruction Of Cervical Cancer ...

February 8, 2022

V.TLT

$TLTFF Destruction Of Throat Cancer

Theralase Lead Anti-Cancer Drug Effective In The Destruction Of Throat Cancer...

February 8, 2022

V.TLT

$TLTFF Theralase® Anti-Cancer Validated Colorectal Cancer

Theralase® Anti-Cancer Vaccine Validated In Colorectal Cancer Toronto,...

February 8, 2022

V.TLT

Theralase Technologies Inc. V.TLT.W

Theralase warrants are sold in an open market. Theralase Technologies Inc...

February 8, 2022

V.TLT

$TLTFF Theralase® Cold Laser Therapy Enhances Cancer Destruc

Theralase® Discovers Theralase® Cold Laser Therapy Enhances Cancer...

February 8, 2022

V.TLT

$TLTFF Destruction Of Human Lung Cancer

Theralase® Advances Anti-Cancer Technology In Destruction Of Human Lung...

February 8, 2022

V.TLT

$TLTFF Cannabinoid Increases Efficacy Of Patented Anti-Cance

Theralase® Discovers Cannabinoid Increases Efficacy Of Patented Anti...

February 8, 2022

V.TLT

$TLTFF Shows Promise For Esophageal Cancer

Theralase® Anti-Cancer Technology Shows Promise For Esophageal Cancer...

February 8, 2022

V.TLT

$TLTFF Immune Response To Destroy Human Brain Cancer Cells

Theralase’s Rutherrin® Photo Dynamic Therapy Induces Immune Response To...

February 8, 2022

Featured Company